AQP3 (Aquaporin-3) variants and mutations
AQP3 (also known as Aquaporin-3) is a human protein-coding gene encoding an aquaporin-3 protein. It transports water and small neutral solutes such as glycerol across epithelial membranes and contributes to skin hydration, cell migration, and metabolic homeostasis. Rare loss-of-function variants define the GIL blood-group system and can alter epithelial water and glycerol handling. This analysis covers 500 AQP3 variants and mutations. Of these, 83% have computational variant effect predictions. Disease context includes neurodegenerative disease, COVID-19, and atopic eczema. Example AQP3 variants include G2S, R3L, and Q4L.
Variant analysis overview
- Gene: AQP3
- Protein: Aquaporin-3
- UniProt accession: Q92482
- Organism: Homo sapiens
- Variants analyzed: 500
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 283 unspecified-consequence records; 2 stop lost; 66 synonymous variants; 115 missense variants; 25 frameshift variants; 4 stop-gained variants; 5 in-frame deletions
- Prediction scores: 415 variants have prediction scores (83% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: neurodegenerative disease, COVID-19, atopic eczema, hepatocellular carcinoma, gastric cancer, neoplasm, lung adenocarcinoma, breast carcinoma, breast cancer, cancer, cervical carcinoma, non-small cell lung carcinoma.
Protein structure and variant hotspots
- Protein features: 6 transmembrane segments; 1 post-translational modification sites.
- Structural context: 152 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable AQP3 variants
Examples include G2S, R3L, Q4L, Q4P, K5R, L7P, V8L, S9C. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- G2S (p.Gly2Ser), gnomAD rs1424334828, REVEL 0.28, CADD 25.30
- R3L (p.Arg3Leu), ExAC rs752949682, TOPMed rs752949682, gnomAD rs752949682, REVEL 0.46, CADD 23.60
- Q4L (p.Gln4Leu), TOPMed rs1481293569, gnomAD rs1481293569, REVEL 0.49, CADD 31.00
- Q4P (p.Gln4Pro), TOPMed rs1481293569, gnomAD rs1481293569, REVEL 0.57, CADD 31.00, Uncertain significance, not specified
- K5R (p.Lys5Arg), ExAC rs765311734, TOPMed rs765311734, gnomAD rs765311734, REVEL 0.29, CADD 24.80
- L7P (p.Leu7Pro), gnomAD rs1180932340, REVEL 0.51, CADD 24.00
- V8L (p.Val8Leu), rs759820093, ClinGen CA5026539, ClinVar RCV004363470, ExAC rs759820093, REVEL 0.14, CADD 15.80, Uncertain significance, not specified
- S9C (p.Ser9Cys), ExAC rs754206115, TOPMed rs754206115, gnomAD rs754206115, REVEL 0.32, CADD 23.50
- S9F (p.Ser9Phe), ExAC rs754206115, TOPMed rs754206115, gnomAD rs754206115, REVEL 0.23, CADD 23.70
- R10H (p.Arg10His), gnomAD rs1826932867, REVEL 0.39, CADD 23.70
- R10S (p.Arg10Ser), ExAC rs766881900, gnomAD rs766881900, REVEL 0.34, AlphaMissense 0.13
- G12E (p.Gly12Glu), TOPMed rs1326007663, gnomAD rs1326007663, REVEL 0.16, CADD 18.80
- G12R (p.Gly12Arg), ExAC rs773909054, TOPMed rs773909054, gnomAD rs773909054, REVEL 0.31, AlphaMissense 0.16, Uncertain significance, not specified
- G12V (p.Gly12Val), TOPMed rs1326007663, gnomAD rs1326007663
- G12W (p.Gly12Trp), cosmic curated COSV99955, ExAC rs773909054, TOPMed rs773909054, gnomAD rs773909054, REVEL 0.42, AlphaMissense 0.06, Uncertain significance
- E13* (p.Glu13Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E13D (p.Glu13Asp), ESP rs368353913, TOPMed rs368353913, REVEL 0.15, AlphaMissense 0.10
- M14K (p.Met14Lys), gnomAD rs1409387650, REVEL 0.22, CADD 22.80
- M14V (p.Met14Val), gnomAD rs900221905, REVEL 0.23, AlphaMissense 0.11
- L15P (p.Leu15Pro), TOPMed rs1826932440, REVEL 0.72, CADD 27.00
- L15V (p.Leu15Val), Ensembl rs376385241, REVEL 0.30, CADD 22.50
- H16R (p.His16Arg), gnomAD rs1348741263, REVEL 0.23, CADD 19.30
- Y19H (p.Tyr19His), gnomAD rs1300008376, REVEL 0.18, CADD 20.20
- R20Q (p.Arg20Gln), gnomAD rs1358573565, REVEL 0.18, CADD 20.90
- R20W (p.Arg20Trp), TOPMed rs1442989277, gnomAD rs1442989277, REVEL 0.43, CADD 27.70
- L21P (p.Leu21Pro), TOPMed rs1332036044, gnomAD rs1332036044, REVEL 0.53, CADD 31.00
- L21V (p.Leu21Val), rs1826932060, ClinGen CA373200210, ClinVar RCV004164680, Ensembl rs1826932060, REVEL 0.25, CADD 24.50, Uncertain significance, not specified
- L22F (p.Leu22Phe), ExAC rs768201326, gnomAD rs768201326, REVEL 0.39, CADD 23.40
- L22V (p.Leu22Val), ExAC rs768201326, gnomAD rs768201326, REVEL 0.21, CADD 18.50
- R23G (p.Arg23Gly), ExAC rs762440965, gnomAD rs762440965, REVEL 0.80, CADD 29.40
- R23L (p.Arg23Leu), TOPMed rs1158008302, gnomAD rs1158008302, REVEL 0.82, CADD 26.70
- R23Q (p.Arg23Gln), TOPMed rs1158008302, gnomAD rs1158008302, REVEL 0.72, CADD 26.90
- A25E (p.Ala25Glu), TOPMed rs1826931533, REVEL 0.21, CADD 25.00
- A25T (p.Ala25Thr), ExAC rs775067063, TOPMed rs775067063, gnomAD rs775067063, REVEL 0.13, CADD 22.50
- E28D (p.Glu28Asp), gnomAD rs1489743207, REVEL 0.70, AlphaMissense 0.97
- C29R (p.Cys29Arg), gnomAD rs1482639297, REVEL 0.83, CADD 26.10
- G31R (p.Gly31Arg), TOPMed rs1201009715
- T32I (p.Thr32Ile), Ensembl rs867437626, REVEL 0.50, CADD 24.20
- L33F (p.Leu33Phe), gnomAD rs1237412703, REVEL 0.23, AlphaMissense 0.88
- I34V (p.Ile34Val), ExAC rs780924525, gnomAD rs780924525, REVEL 0.31, CADD 17.40
- V36E (p.Val36Glu), ExAC rs758362320, TOPMed rs758362320, gnomAD rs758362320, REVEL 0.89, CADD 26.40
- V36L (p.Val36Leu), gnomAD rs1315402999, REVEL 0.47, CADD 23.00
- M37I (p.Met37Ile), gnomAD rs1432636423, REVEL 0.31, CADD 22.40
- V43A (p.Val43Ala), Ensembl rs1587199446
- V43G (p.Val43Gly), Ensembl rs1587199446
- V43M (p.Val43Met), rs34942735, UniProt VAR 025089, 1000Genomes rs34942735, ESP rs34942735, REVEL 0.26, CADD 24.90
- Q45H (p.Gln45His), Ensembl rs59981139
- Q45P (p.Gln45Pro), gnomAD rs1347722135
- V46A (p.Val46Ala), ExAC rs748149295, TOPMed rs748149295, gnomAD rs748149295, REVEL 0.30, CADD 17.70
- V46F (p.Val46Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V46G (p.Val46Gly), ExAC rs748149295, TOPMed rs748149295, gnomAD rs748149295, REVEL 0.68, CADD 22.30
- V47A (p.Val47Ala), NCI-TCGA Cosmic COSV5304, cosmic curated COSV53048, Variant assessed as somatic; moderate impact.
- V47M (p.Val47Met), cosmic curated COSV53048, ExAC rs778828841, gnomAD rs778828841, REVEL 0.68, CADD 23.10
- R50G (p.Arg50Gly), ExAC rs749513194, TOPMed rs749513194, gnomAD rs749513194
- R50Q (p.Arg50Gln), ExAC rs780493653, TOPMed rs780493653, gnomAD rs780493653, REVEL 0.03, CADD 18.10
- R50W (p.Arg50Trp), cosmic curated COSV53048, ExAC rs749513194, TOPMed rs749513194, gnomAD rs749513194, REVEL 0.13, CADD 23.50
- G51D (p.Gly51Asp), gnomAD rs940868590, REVEL 0.18, CADD 23.20
- G54S (p.Gly54Ser), NCI-TCGA Cosmic COSV5304, cosmic curated COSV53047, REVEL 0.29, CADD 24.20, Variant assessed as somatic; moderate impact.
- G55S (p.Gly55Ser), ExAC rs750756921, gnomAD rs750756921, REVEL 0.11, AlphaMissense 0.96
- F56Y (p.Phe56Tyr), ESP rs374961919, ExAC rs374961919, TOPMed rs374961919, gnomAD rs374961919, REVEL 0.55, CADD 23.80
- T58P (p.Thr58Pro), Ensembl rs1587199364
- I59V (p.Ile59Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N60S (p.Asn60Ser), NCI-TCGA Cosmic COSV5304, NCI-TCGA Cosmic COSV9995, cosmic curated COSV99955, Variant assessed as somatic; moderate impact.
- N60T (p.Asn60Thr), NCI-TCGA Cosmic COSV5304, cosmic curated COSV53049, NCI-TCGA Cosmic COSV9995, Variant assessed as somatic; moderate impact.
- V67A (p.Val67Ala), rs752146716, ExAC rs752146716, AlphaMissense 0.58, MetaLR 0.55, Variant assessed as somatic; moderate impact.
- V67I (p.Val67Ile), gnomAD rs1360176337, REVEL 0.53, CADD 24.00
- G70D (p.Gly70Asp), gnomAD rs1225083688, REVEL 0.78, CADD 24.30
- G70S (p.Gly70Ser), gnomAD rs1826877100, REVEL 0.66, CADD 26.70
- A74S (p.Ala74Ser), TOPMed rs1385987539, gnomAD rs1385987539, REVEL 0.11, CADD 17.50, Uncertain significance
- A74T (p.Ala74Thr), rs1385987539, ClinGen CA373198235, ClinVar RCV004096629, TOPMed rs1385987539, REVEL 0.18, CADD 22.40, Uncertain significance, not specified
- G75D (p.Gly75Asp), NCI-TCGA Cosmic COSV5304, cosmic curated COSV53047, Variant assessed as somatic; moderate impact.
- G75S (p.Gly75Ser), ExAC rs765960239, TOPMed rs765960239, gnomAD rs765960239, REVEL 0.49, CADD 29.10
- V77I (p.Val77Ile), TOPMed rs1354430795, gnomAD rs1354430795, REVEL 0.32, CADD 21.30
- G79R (p.Gly79Arg), TOPMed rs1009080611
- A80S (p.Ala80Ser), ExAC rs781532774, gnomAD rs781532774, REVEL 0.30, AlphaMissense 0.98
- A80V (p.Ala80Val), Ensembl rs778212126, REVEL 0.32, CADD 26.20
- H81Q (p.His81Gln), TOPMed rs1826870647, REVEL 0.92, AlphaMissense 0.84
- N83T (p.Asn83Thr), Ensembl rs1587198917
- P84S (p.Pro84Ser), gnomAD rs1184048384
- A85D (p.Ala85Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A85V (p.Ala85Val), gnomAD rs1464221016, REVEL 0.61, CADD 31.00
- V86A (p.Val86Ala), ExAC rs758863165, gnomAD rs758863165
- V86M (p.Val86Met), rs778133652, ClinGen CA5026458, cosmic curated COSV53048, ClinVar RCV004085571, REVEL 0.90, CADD 26.60, Uncertain significance, not specified
- T87I (p.Thr87Ile), TOPMed rs1264388787, gnomAD rs1264388787, REVEL 0.67, CADD 28.30
- M90I (p.Met90Ile), gnomAD rs867265809, cosmic curated COSV10513
- C91* (p.Cys91Ter), gnomAD rs1326155172, CADD 33.00
- A94D (p.Ala94Asp), TOPMed rs1401676584, gnomAD rs1401676584, REVEL 0.31, CADD 27.40
- R95H (p.Arg95His), ExAC rs201240634, TOPMed rs201240634, gnomAD rs201240634, REVEL 0.65, CADD 24.10
- E96D (p.Glu96Asp), TOPMed rs1316539605, gnomAD rs1316539605, REVEL 0.48, AlphaMissense 0.36
- E96K (p.Glu96Lys), ExAC rs779519202, gnomAD rs779519202, REVEL 0.57, AlphaMissense 0.28
- P97H (p.Pro97His), Ensembl rs2118969997
- P97L (p.Pro97Leu), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99955, Variant assessed as somatic; moderate impact.
- W98* (p.Trp98Ter), ExAC rs755681406, TOPMed rs755681406, gnomAD rs755681406, CADD 39.00
- W98C (p.Trp98Cys), gnomAD rs1385919354, REVEL 0.69, CADD 31.00
- I99T (p.Ile99Thr), TOPMed rs1163076998, gnomAD rs1163076998, REVEL 0.43, CADD 23.40
- K100N (p.Lys100Asn), gnomAD rs1422821270, REVEL 0.73, CADD 23.50
- I103L (p.Ile103Leu), TOPMed rs1387022873, gnomAD rs1387022873
- I103V (p.Ile103Val), TOPMed rs1387022873, gnomAD rs1387022873
- Y104C (p.Tyr104Cys), ExAC rs750041458, gnomAD rs750041458, REVEL 0.85, CADD 25.10
- T105A (p.Thr105Ala), cosmic curated COSV10813, gnomAD rs1826869202
- T105S (p.Thr105Ser), gnomAD rs1826869202, REVEL 0.25, AlphaMissense 0.11
- L106P (p.Leu106Pro), gnomAD rs1447267220, REVEL 0.84, CADD 25.10
- L106V (p.Leu106Val), ExAC rs767135708, TOPMed rs767135708, gnomAD rs767135708, REVEL 0.41, AlphaMissense 0.13
- A107V (p.Ala107Val), gnomAD rs1266211169, REVEL 0.23, CADD 22.00
- T109M (p.Thr109Met), cosmic curated COSV10883, ExAC rs761390305, TOPMed rs761390305, gnomAD rs761390305, REVEL 0.57, CADD 22.90
- T109R (p.Thr109Arg), ExAC rs761390305, TOPMed rs761390305, gnomAD rs761390305, REVEL 0.78, CADD 24.00
- G111R (p.Gly111Arg), gnomAD rs1294602134
- A112D (p.Ala112Asp), gnomAD rs1339268891, REVEL 0.49, CADD 26.60
- A112S (p.Ala112Ser), gnomAD rs1247288996, REVEL 0.19, AlphaMissense 0.99
- L114F (p.Leu114Phe), ExAC rs764008707, gnomAD rs764008707
- A116C (p.Ala116Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- A116S (p.Ala116Ser), gnomAD rs1826868366, REVEL 0.51, AlphaMissense 0.98
- G117* (p.Gly117Ter), NCI-TCGA TCGA novel, CADD 38.00, Variant assessed as somatic; high impact.
- G117R (p.Gly117Arg), gnomAD rs1826868309, REVEL 0.87, CADD 29.10
- V119F (p.Val119Phe), cosmic curated COSV53048, TOPMed rs1258943974, gnomAD rs1258943974, REVEL 0.64, CADD 21.80
- F120L (p.Phe120Leu), NCI-TCGA TCGA novel, TOPMed rs925234297, REVEL 0.21, AlphaMissense 0.81, Variant assessed as somatic; high impact.
- L122V (p.Leu122Val), gnomAD rs1327317379, REVEL 0.38, CADD 22.80
- Y123C (p.Tyr123Cys), Ensembl rs1826868168, REVEL 0.66, CADD 31.00
- A126T (p.Ala126Thr), cosmic curated COSV53047, gnomAD rs1262959318, REVEL 0.37, CADD 26.50
- A126A (p.Ala126Ala), rs1764121327, gnomAD 9-33442966-T-C, CADD 5.57
- A126C (p.Ala126Cys), gnomAD 9-33442968-C-CA, CADD 31.00
- A126S (p.Ala126Ser), gnomAD 9-33442968-C-A, REVEL 0.22, MetaLR 0.10
- I127I (p.Ile127Ile), gnomAD 9-33442963-G-A, CADD 8.37
- I127S (p.Ile127Ser), gnomAD 9-33442964-AT-A, CADD 25.90
- I127V (p.Ile127Val), gnomAD 9-33442965-T-C, REVEL 0.14, MetaLR 0.08
- H129D (p.His129Asp), TOPMed rs768715017, gnomAD rs768715017, REVEL 0.05, CADD 0.18
- H129Y (p.His129Tyr), TOPMed rs768715017, gnomAD rs768715017, REVEL 0.06, CADD 0.37
- H129H (p.His129His), gnomAD 9-33442957-G-A, AlphaMissense 0.09, MetaLR 0.02
- F130L (p.Phe130Leu), 1000Genomes rs2228332, ESP rs2228332, ExAC rs2228332, TOPMed rs2228332, Benign
- F130F (p.Phe130Phe), rs2228332, gnomAD 9-33442954-G-A, CADD 1.01
- A131G (p.Ala131Gly), ExAC rs770956892, gnomAD rs770956892, REVEL 0.04, AlphaMissense 0.98
- A131T (p.Ala131Thr), TOPMed rs774972543, gnomAD rs774972543, REVEL 0.14, CADD 13.30
- A131V (p.Ala131Val), ExAC rs770956892, gnomAD rs770956892
- A131A (p.Ala131Ala), rs760931129, gnomAD 9-33442951-G-A, CADD 4.01
- A131D (p.Ala131Asp), gnomAD 9-33442952-G-T, REVEL 0.04, AlphaMissense 0.98
- D132H (p.Asp132His), 1000Genomes rs2231233, ESP rs2231233, ExAC rs2231233, TOPMed rs2231233, REVEL 0.08, CADD 14.50
- D132N (p.Asp132Asn), cosmic curated COSV53047, 1000Genomes rs2231233, ESP rs2231233, ExAC rs2231233, REVEL 0.02, CADD 4.23
- D132Y (p.Asp132Tyr), 1000Genomes rs2231233, ESP rs2231233, ExAC rs2231233, TOPMed rs2231233, REVEL 0.06, CADD 14.10
- N133K (p.Asn133Lys), ESP rs372392094, ExAC rs372392094, TOPMed rs372392094, gnomAD rs372392094, REVEL 0.10, CADD 8.47
- N133S (p.Asn133Ser), ExAC rs748446670, TOPMed rs748446670, gnomAD rs748446670, REVEL 0.15, CADD 20.50
- N133N (p.Asn133Asn), rs372392094, gnomAD 9-33442945-G-A, CADD 0.81
- Q134E (p.Gln134Glu), Ensembl rs2118968338, REVEL 0.06, CADD 0.39
- Q134R (p.Gln134Arg), TOPMed rs1826860836
- L135I (p.Leu135Ile), cosmic curated COSV53048, ExAC rs769161680, gnomAD rs769161680, REVEL 0.10, CADD 22.30
- L135V (p.Leu135Val), ExAC rs769161680, gnomAD rs769161680
- F136L (p.Phe136Leu), gnomAD rs1826860721, REVEL 0.02, AlphaMissense 0.10
- F136Y (p.Phe136Tyr), Ensembl rs2118968306
- V137A (p.Val137Ala), gnomAD 9-33442934-A-G, REVEL 0.33, MetaLR 0.08
- V137D (p.Val137Asp), gnomAD 9-33442934-A-T, REVEL 0.53, AlphaMissense 0.38
- V137F (p.Val137Phe), gnomAD 9-33442934-AC-A, CADD 25.10
- S138L (p.Ser138Leu), rs749786864, ExAC rs749786864, TOPMed rs749786864, gnomAD rs749786864, REVEL 0.06, CADD 23.20, Variant assessed as somatic; moderate impact.
- S138S (p.Ser138Ser), rs1334511730, gnomAD 9-33442930-C-T, CADD 6.73
- S138A (p.Ser138Ala), gnomAD 9-33442932-A-C, REVEL 0.08, AlphaMissense 0.74
- P140A (p.Pro140Ala), gnomAD rs1470831829, REVEL 0.07, CADD 19.60
- P140T (p.Pro140Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P140P (p.Pro140Pro), rs1563866785, gnomAD 9-33442924-G-T, AlphaMissense 0.12, MetaLR 0.03
- P140L (p.Pro140Leu), gnomAD 9-33442925-G-A, REVEL 0.16, MetaLR 0.05
- N141S (p.Asn141Ser), ExAC rs780717697, TOPMed rs780717697, gnomAD rs780717697, REVEL 0.35, CADD 22.50, Uncertain significance, not specified
- N141N (p.Asn141Asn), gnomAD 9-33442921-A-G, CADD 4.82
- N141D (p.Asn141Asp), gnomAD 9-33442923-T-C, REVEL 0.33, MetaLR 0.48
- G142D (p.Gly142Asp), TOPMed rs1826860281, Uncertain significance, not specified
- G142R (p.Gly142Arg), gnomAD rs1157846018
- T143R (p.Thr143Arg), ExAC rs756763951, TOPMed rs756763951, gnomAD rs756763951, REVEL 0.59, CADD 27.80
- T143T (p.Thr143Thr), gnomAD 9-33442915-T-G, AlphaMissense 0.82, MetaLR 0.14
- T143S (p.Thr143Ser), gnomAD 9-33442917-T-A, REVEL 0.32, MetaLR 0.09
- T143A (p.Thr143Ala), gnomAD 9-33442917-T-C, REVEL 0.38, MetaLR 0.10
- A144A (p.Ala144Ala), rs547088243, gnomAD 9-33442912-G-A, CADD 2.01
- A144S (p.Ala144Ser), rs1275018837, gnomAD 9-33442914-C-CT, CADD 31.00
- G145C (p.Gly145Cys), ExAC rs777633399, TOPMed rs777633399, gnomAD rs777633399, REVEL 0.50, CADD 27.90
- G145D (p.Gly145Asp), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99955, TOPMed rs1826859975, REVEL 0.39, CADD 25.80, Variant assessed as somatic; moderate impact.
- G145S (p.Gly145Ser), rs777633399, NCI-TCGA Cosmic COSV9995, cosmic curated COSV99955, ExAC rs777633399, REVEL 0.29, CADD 23.70, Variant assessed as somatic; moderate impact.
- I146T (p.Ile146Thr), ExAC rs758126339, gnomAD rs758126339, REVEL 0.62, CADD 27.60
- I146I (p.Ile146Ile), gnomAD 9-33442906-G-A, CADD 12.10
- A148V (p.Ala148Val), gnomAD 9-33442901-G-A, REVEL 0.41, MetaLR 0.11
- A148T (p.Ala148Thr), gnomAD 9-33442902-C-T, REVEL 0.17, MetaLR 0.07
- A148S (p.Ala148Ser), gnomAD 9-33442902-C-A, REVEL 0.15, MetaLR 0.05
- T149T (p.Thr149Thr), rs775403743, gnomAD 9-33442897-G-A, CADD 12.00
- Y150* (p.Tyr150Ter), Ensembl rs1826859825
- P151A (p.Pro151Ala), Ensembl rs1826859780, REVEL 0.52, CADD 26.70, Uncertain significance, not specified
- P151P (p.Pro151Pro), rs143323747, gnomAD 9-33442891-G-A, AlphaMissense 0.88, MetaLR 0.15
Public AQP3 analysis runs
- AQP3 analysis run — AQP3 (500 variants) — completed 2026-08-20